CSFタンパク質バイオマーカーは、遺伝性FTDにおける萎縮および症状重症度と関連している:GENFI研究
Abbe Ullgren1,2, Melissa Taheri Rydell3,4, Sofia Bergström5
1Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden. abbe.ullgren@ki.se.
Journal of neural transmission (Vienna, Austria : 1996)
|February 19, 2026
まとめ
No abstract available in PubMed .


